CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 38 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,718,000 | +11.1% | 3,673,374 | 0.0% | 2.60% | +36.8% |
| Q4 2021 | $10,543,000 | -27.7% | 3,673,374 | 0.0% | 1.90% | +30.7% |
| Q3 2021 | $14,583,000 | -33.4% | 3,673,374 | 0.0% | 1.45% | -43.8% |
| Q2 2021 | $21,893,000 | -50.9% | 3,673,374 | 0.0% | 2.58% | -39.0% |
| Q1 2021 | $44,595,000 | -16.8% | 3,673,374 | 0.0% | 4.24% | -10.4% |
| Q4 2020 | $53,595,000 | +26.8% | 3,673,374 | 0.0% | 4.73% | -26.4% |
| Q3 2020 | $42,281,000 | – | 3,673,374 | – | 6.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|